In vitro antibacterial efficacy of tetracycline hydrochloride adsorbed onto Bio-Oss® bone graft

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 93, Issue 2, 2010, Pages 394-400

  Dashti, A ^a   Ready, D ^b   Salih, V ^a   Knowles, J C ^a   Barralet, J E ^c   Wilson, M ^a   Donos, N ^a   Nazhat, S N ^a,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Antibiotics; Antimicrobial; Bio Oss ; Bone graft; Infection; Local delivery; Peri implantitis; Periodontal disease

Indexed keywords

BONE GRAFT; INFECTION; LOCAL DELIVERY; PERI-IMPLANTITIS; PERIODONTAL DISEASE;

ANTIBIOTICS; BACTERIOLOGY; BIOLOGICAL MATERIALS; BIOMATERIALS; BONE; CELL CULTURE; CONCENTRATION (PROCESS); ENZYME INHIBITION; GRAFTING (CHEMICAL); GRAFTS; SOLUTIONS;

BACTERIA;

PHOSPHATE BUFFERED SALINE; TETRACYCLINE;

ADSORPTION; AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ANTIBACTERIAL ACTIVITY; AQUEOUS SOLUTION; ARTICLE; BONE GRAFT; BONE INFECTION; CELL PROLIFERATION; CYTOTOXICITY TEST; DRUG CYTOTOXICITY; DRUG EFFICACY; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; OSTEOBLAST; OSTEOSARCOMA CELL; PERIODONTAL DISEASE; PORPHYROMONAS GINGIVALIS; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; BONE REGENERATION; BONE SUBSTITUTES; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG DELIVERY SYSTEMS; HUMANS; MINERALS; TETRACYCLINE;

EID: 77951170012     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31594     Document Type: Article

References (55)

1. Bayston R. 1999. Medical problems due to biofilms: Clinical impact, aetiology, molecular pathogenesis, treatment and prevention. In: Newman HN,Wilson M, editors. Dental Plaques Revisited: Oral Biofilms in Health and Disease. Cardiff, UK: Bioline.
2. An YH, Friedman RJ. Concise review of mechanisms of bacterial adhesion to biomaterial surfaces. J Biomed Mater Res 1998;43: 338-348.
3. Leanhardt A, Renvert S, Dahlan G. Microbial findings at failing implants. Clin Oral Implant Res 1999;10:339-345.
4. Gristina AG, Oga M, Webb LX, Hobgood CD. Adherant bacterial colonization in the pathogenesis of osteomyelitis. Science 1985; 24:990-993. (Pubitemid 15037520)
5. Zitzmann NU, Berglundh T, Ericsson I, Lindhe J. Spontaneous progression of experimentally induced peri-implantitis. J Clin Periodontol 2004;31:845-849. (Pubitemid 39387414)
6. Winkler H, Janata O, Berger C, Weiss W, Georgopoulos A. In vitro release of vancomycin and tobramycin from impregnated human and bovine bone grafts. J Antimicrobial Chemotherapy 2000;46: 423-428.
7. Kanellakopoulou K, Giamarellos-Bourboulis EJ. Carrier systems for local delivery of antibiotics in bone infections. Drugs 2000;59: 1223-1232. (Pubitemid 30410141)
8. Schwartz Z, Kiesweeter K, Dean DD, Boyan BD. Underlying mechanisms at the bone-surface interface during regeneration. J Periodontal Res 1997;32:166-171. (Pubitemid 127521669)
9. Mombelli A, Feloutzis A, Bragger U, Land N. Treatment of periimplantitis by local delivery of tetracycline. Clinical, microbiological and radiological results. Clin Oral Implant Res 2001;12:287-294.
10. Buchter A, Meyer U, Kruse-losler B, Joos U. Sustained release of doxycycline for the treatment of peri-implantitis: randomised controlled trail. Br J Oral Maxillofacial Surg 2004;42:439-444. (Pubitemid 39186047)
11. Renvert S, Lessem J, Dahlen G, Lindahl C, Svensson M. Topical minocycline microshperes versus topical chlorhexidine gel as an adjunct to mechanical debridment of incipient peri-implant infections: A randomised clinical trial. J Clin Periodontol 2006;33: 362-369. (Pubitemid 43549771)
12. Persson GR, Salvi GE, Heitz-Mayfield LJA, Lang NP. Antimicrobial therapy using a local drug delivery system (Arestin®) in the treatment of peri-implantitis. I. Microbilogical outcomes. Clin Oral Implant Res 2006;17:386-393.
13. Peetz M. Characterization of xenogeneic bone mineral. In: Boyne PJ, editor. Osseous Reconstruction of the Maxilla and the Mandible: Surgical Techniques Using Titanium Mesh and Bone Mineral. Chicago: Quintessence; 1997. pp 87-100.
14. Richardson CR, Mellonig JT, McDonnell HT, Cochran DL. Clinical evaluation of Bio-Oss®: A bovine-derived xenograft for the treatment of periodontal osseous defects in humans. J Clin Periodontol 1999;26:421-428.
15. Tapety FI, Amizuka A, Uoshima K, Nomura S, Maeda T. A histological evaluation of the involvement of Bio-Oss in oestoblastic differentiation and matrix synthesis. Clin Oral Implant Res 2004; 15:315-324. (Pubitemid 40340573)
16. Hämmerle CH, Karring T. Guided bone regeneration at oral implant sites. Periodontology 2000 1998;17:151-175. (Pubitemid 128556026)
17. Donos N, Lang NP, Karoussis K, Bosshardt D, Tonetti M, Kostopoulous L. Effect of GBR in combination with deproteinised bovine bone minerals/ or enamel matrix proteins on healing of critical size defects. Clin Oral Implant Res 2004;15:101-111. (Pubitemid 38686951)
18. Benke D, Olah A, Mohler H. Protein-chemical analysis of Bio-Oss bone substitute and evidence on its carbonate content. Biomaterials 2001;22:1005-1012. (Pubitemid 32201452)
19. Becker W. Treatment of small defects adjacent to oral implants with various biomaterials. Periodontology 2000 2003;33:26-35. (Pubitemid 37487552)
20. Sculean T, Stavropoulos A, Windisch P, Keglevich T, Karring T, Gera I. Healing of human intrabony defects following regenerative periodontal therapy with a bovine-derived xenograft and guided tissue regeneration. Clin Oral Invest 2004;8:70-74.
21. Slots J, Rams TE. Antibiotics in periodontal therapy: Advantages and disadvantages. J Clin Periodontol 1990;17:479-493. (Pubitemid 20231076)
22. Davies AK, Cundall RB, Dandiker Y, Slifkin MA. Photo-oxidation of tetracycline adsorbed on hydroxyapatite in relation to the light-induced staining of teeth. J Dental Res 1985;64:936-939. (Pubitemid 15052239)
23. Albert A, Rees CW. Avidity of tetracyclines for the cations of metals. Nature 1956;177:433-434.
24. Deleu J, Bohr H. Uptake of tetracycline by human bone in vitro. Nature 1964;204:1103-1104.
25. Misra DN. Adsorption and orientation of tetracyclines on hydroxyapatite. Calcified Tissue Int 1991;48:362-367.
26. Clover J, Gowen M. Are MG-63 and HOS TE85 human osteosarchoma cell lines representative modles of the osteoblastic phenotype? Bone 1985;15:585-591.
27. Mombelli A. Microbiology and antimicrobial therapy of periimplantitis. Periodontology 2000 2002;28:177-189.
28. Al Ali W, Bissada NF, Greenwell H. The effect of local doxycycline with and without tricalcium phosphate on the regenerative healing potential of periodontal osseous defects in dogs. J Periodontol 1989;10:582-590. (Pubitemid 20046185)
29. Drury GI, Yukna RA. Histologic evaluation of combining tetracycline and allogenic freeze dried bone on bone regeneration in experimental defects in baboons. J Periodontol 1991;62:652-658.
30. Ginebra, M-P, Traykova T, Planell JA. Calcium phosphate cements: Competitive drug carries for the musculoskeletal system. Biomaterials 2006;27:2171-2177. (Pubitemid 41782020)
31. Young AM, Ng PYJ, Gbureck U, Nazhat SN, Barralet JE, Hofmann MP. Characterisation of chlorhexidine releasing, fast-setting, brushite bone cements. Acta Biomaterialia 2008;4:1081-1088.
32. Ratier A, Gibson IR, Best SM, Freche M, Lacout JL, Rodreguez F. Setting characteristics and mechanical behaviour of a calcium phosphate bone cement containing tetracycline. Biomaterials 2001;22:897-901. (Pubitemid 32201440)
33. Norowski PA and Bumgardner JD. Biomaterial and antibiotic strategies for peri-implantitis. J Biomed Mater Res B Appl Biomaterls 2009;88:530-543.
34. Stigter M, Bezemer J, De Groot K, Layrolle P. Incorporation of different hydroxyapatite coatings on titanium implants, release and antibiotic efficacy. J Control Release 2004;14:127-137.
35. Saito T, Takeuchi R, Hirakawa K, Nagata N, Yoshida T, Koshino T, Okuda K, Takema M, Hori T. Slow releasing potential of vancomycin- loaded porous hydroxyapatites blocks implanted into MRSA osteomyelitis. J Biomed Mater Res 2002;63:245-251. (Pubitemid 34521326)
36. Queiroz AC, Santos JD, Monterio FJ, Gibson IR, Knowles JC. Adsorption and release studies of sodium ampicillin from hydroxyapatites composites. Biomaterials 2001;22:1393-1400.
37. Wang D, Miller SC, Kopeckova P, Kopecek J. Bone targetting macromolecular therapeutics. Adv Drug Deliv Rev 2005;57: 1049-1076.
38. Perrin DD. Binding of tetracycline to bone. Nature 1965;208: 787-788.
39. Huang WC, Zeng H, Weng LL. Synthesis of tetracycline analogs. Chinese Chem Lett 2008;19:19-22.
40. Ayako Oyane Yoshiro Yokoyama, Masaki Uchida, Atsuo Ito.The formation of an antibacterial agent-apatite composite coating on a polymer surface using a metastable calcium phosphate solution. Biomaterials 27;2006:3295-3303.
41. Murugan R, Ramakrishna S. Coupling of therapeutic molecules onto surface modified coralline hydroxyapatite. Biomaterials 2004;25:3073-3080. (Pubitemid 38213149)
42. National Committee for Clinical Laboratory Standards Methods for dilution antimicrobial tests for bacteria that grow aerobically, Sixth Edition: Approved standard M07-A6.NCCLS, Villanova, PA: NCCLS 2003.
43. National Committee for Clinical Laboratory Standards Methods for antimicrobial susceptibility testing of anaerobic bacteria, Fifth Edition: Approved Standard M11-A5.NCCLS, Villanova, PA: NCCLS 2003.
44. Gordon JM, Walker CB, Murphy JC, Goodson JM, Socransky SS. Tetracycline: Levels achievable in gingival crevice fluid and in vitro effect on subgingival organisms. I. Concentrations in crevicular fluid after repeated doses. J Periodontol 1981;52:609-612.
45. Walker CB, Gordon JM, McQuilkin SJ, Niebloom TA, Socransky SS. Tetracycline: Levels of achievable in gingival crevice fluid and in vitro effect on subgingival organisms. II. Susceptibilities of periodontal bacteria. J Periodontol 1981;52:613-616. (Pubitemid 12250796)
46. Goodson JM, Holborow D, Dunn RL, Hogan P, Dunham S. Monolithic tetracycline for controlled delivery to periodontal pockets. J Periodontol 1983;54:575-579. (Pubitemid 14245629)
47. Tonetti MS, Cugini MA, Goodson JM. Zero-order delivery with periodontal placement of tetracycline-loaded ethylene vinyl acetate fibres. J Periodontal Res 1990;25:243-249.
48. Needleman IG, Gerkach RW, Baker AR, Damani NC, Smith ST, Smales F. Retention, antimicrobial activity, and clinical outcomes following use of a bioerodible tetracycline gel in moderate-to-deep periodontal pockets. J Periodontol 1998;69:578-583. (Pubitemid 28255643)
49. Chung CP, Kim DK, Park YJ, Nam KH, Lee SJ. Biological effects of drug loaded biodegradable membranes for guided tissue regeneration. J Periodontal Res 1997;32:172-175.
50. Somerman MJ, Foster RA, Vorsteg G, Progebi K, Wynn RL. Effects of minocycline on fibroblast attachment and spreading. J Periodontal Res 1988;23:154-159.
51. Hartmann A, Wess D, Witte I. Enhanced cyto- and genotoxicity of tetracycline in Wilson disease fibroblasts. Mutat Res 1995;348:7-12.
52. Schwartz Z, Weesner T, Van Dijk S, Cochrane DL, Melloning JT, Lohmann CH, Carnes DL, Goldstien M, Dean DD, Boyan BD. Ability of deproteinised cancellous bovine bone to induce new bone formation. J Periodontol 2000;71:1258-1269.
53. Schwartz Z, Lohmann CH, Wieland M, Cochran DL, Dean DD, Textor M, Bonewald LF, Boyan BD. Osteoblast proliferation and differentiation on dentin slices are modulated by pretreatment of the surface with tetracycline or osteoclasts. J Periodontol 2000;71:586-597. (Pubitemid 30602325)
54. Gomes PS, Fernandes MH. Effect of therapeutic levels of doxycycline and minocycline in the proliferation and differentiation of human bone marrow osteoblastic cells. Arch Oral Biol 2007;52: 251-259. (Pubitemid 46096435)
55. Gomes PS, Santos JD, Fernandes MH. Cell-induced response by tetracyclines on human bone marrow colonized hydroxyapatite and bonelike. Acta Biomaterialia 2008;4:630-637.